Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
11.61
-0.88 (-7.05%)
At close: Jun 26, 2026, 4:00 PM EDT
11.85
+0.24 (2.07%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 36.8, with a low estimate of 12 and a high estimate of 49. The average target predicts an increase of 216.97% from the current stock price of 11.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lyell Immunopharma stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 6 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $44 | Buy | Maintains | $44 | +278.98% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +287.60% | Jun 9, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $12 | Sell | Reiterates | $12 | +3.36% | Jun 3, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Initiates $49 | Buy | Initiates | $49 | +322.05% | Apr 30, 2026 |
| Citizens JMP | Citizens JMP | Buy Initiates $34 | Buy | Initiates | $34 | +192.85% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
13.67K
from 36.00K
Decreased by -62.03%
Revenue Next Year
7.86M
from 13.67K
Increased by 57,430.87%
EPS This Year
-5.70
EPS Next Year
-3.35
from -5.70
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 46,000 | 39.6M | |
| Avg | 13,670 | 7.9M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.8% | 289,642.7% | |
| Avg | -62.0% | 57,430.9% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -5.70 | -3.35 | |
| Avg | -5.70 | -3.35 | |
| Low | -5.70 | -3.35 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.